Ethical Dilemmas in Clinical Research: Resolving Clinical Uncertainty - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Ethical Dilemmas in Clinical Research: Resolving Clinical Uncertainty

Description:

Easily disturbed by investigator bias or hunches 'balancing on ... Individual uncertainty must at the minimum rely on some evidentiary standard to be disturbed ... – PowerPoint PPT presentation

Number of Views:290
Avg rating:5.0/5.0
Slides: 23
Provided by: msararose
Category:

less

Transcript and Presenter's Notes

Title: Ethical Dilemmas in Clinical Research: Resolving Clinical Uncertainty


1
Ethical Dilemmas in Clinical Research Resolving
Clinical Uncertainty
  • M. Sara Rosenthal, Ph.D.
  • Director, Program for Bioethics and Patients
    Rights
  • Co-Chair, Hospital Ethics Committee
  • www.ukhealthcare.uky.edu/bioethics

2
Ethical Principles of the Belmont Report (1979)
  • Respect for Persons Disclosure, informed
    consent, confidentiality
  • Beneficence Risks of research do not outweigh
    potential benefits
  • Justice Burdens and benefits of research be
    evenly distributed among populations

3
What Leads to Belmont?
  • Post WWII
  • 1947 The Nuremberg Code -- in response to Nazi
    medical research atrocities conducted. Largely
    ignored by U.S. scientists. The first sentence
    The voluntary consent of the human subject is
    absolutely essential makes it clear that it is
    NEVER okay to experiment on children.
  • 1930-1970 Tuskegee Syphilis Study (400 Black
    males w/syphilis followed and not treated
    routine spinal taps masked as treatment.)
  • 1951 The U.S. Department of Defence (DOD) adopts
    a formal set of rules based on Nuremberg Code.
    Called the Pentagon policy, created by the Armed
    Forces Medical Policy Council (AFMPC). Not taken
    seriously within the military its existence was
    uncovered in 1994, by the Advisory Committee.

4
Research Ethics in the 1960s
  • 1960s Willowbrook (fed live hep A virus to
    mentally diasabled patients) Jewish Chronic
    Disease Hospital cancer cell study (injected live
    cancer cells into subjects).
  • 1964 The Declaration of Helsinki (World Medical
    Association)
  • 1966 Henry Beechers article in NEJM New
    Guidelines by the PHS, and the creation of
    International Review Boards (IRBs)

5
Research Ethics in the Watergate Era
  • 1972 Three U.S. court informed consent
    landmarks
  • Canterbury v. Spence
  • Cobbs v. Grant
  • Wilkinson V. Vesy
  • From Canterbury The patients right of
    self-decision can be effectively exercised only
    if the patient possesses enough information to
    enable an intelligent choice. The patient should
    make his own determination on treatment. Informed
    consent is a basic social policy...

6
Research Ethics in the Ford Era
  • 1974 Regulations created by the Dept. of Health,
    Edu.,and Welfare (DHEW), which later became the
    Dept. of Health Human Services (DHHS).
  • 1975 National Commission for the Protection of
    Human Subjects of Biomedial and Behavioral
    Research (made up of NIH PHS and HHS) is set up.

7
Research Ethics in the Carter Era
  • 1979 National Commission publishes The Belmont
    Report, famous for its 3 basic ethical
    principles Respect for Persons (NOT
    autonomy) beneficence ( which means do not
    harm maximize possible benefits minimize
    possible harm) and Justice (fairness in
    distribution).

8
4 Core Ethical Principles
  • Respect for Persons Informed consent
    confidentiality
  • Beneficence Improve wellbeing while doing no
    harm (weighing risks versus benefits of research)
  • Non-Malificence Dont inflict harm and dont
    refuse aid (are trials beginning in
    equipoise/uncertainty?)
  • Justice Fairly distribute the burdens and
    benefits of research

9
What Is Informed Consent?
  • Disclosure
  • Capacity and CompetencyUnderstand and
    appreciate
  • Voluntariness
  • Elderly or Minors
  • Neurologically impaired
  • Dementia
  • Depression
  • Anxiety
  • Language and literacy
  • Coercion

10
Nonmalificence
  • A duty not to harm or inflict evil on a
    patient/participant Pharmacovigilance
  • A duty to intervene to prevent imminent harm to
    patient or at-risk third party. Example A duty
    to discontinue a trial?

11
Duty to Warn
  • Legal precedents
  • Tarasoff
  • Pate v. Threlkel
  • Pharmacovigilance A duty to warn of known
    risks
  • Thalidomide
  • DES
  • Dalkon Shield
  • Fen/Phen
  • Vioxx

12
Justice
  • Distributing more fairly the burdens and benefits
    of research
  • Treating all patients/participants equally

13
Vulnerable Populations
  • Less capacity to consent
  • Less access to healthcare
  • More gullible and trusting
  • Not well-represented in clinical or market
    studies women, minorities, children

14
When is it ethical to enroll a patient into an
RCT?
  • When there is genuine uncertainty (Fried, 1974)
  • Frieds Equipoise The INDIVIDUAL
    investigator/physician decides uncertainty
  • The Uncertainty Principle (Peto, 1976 Br J
    Cancer) -- widely used outside U.S.

15
Reframing of Fried and Peto (1987)
  • Clinical Equipoise
  • Uncertainty in the clinical COMMUNITY over
    whether Treatment A is better than Treatment B
  • Investigator bias and hunches do not disturb
    clinical equipoise
  • Clinical trial goal resolve dispute in clinical
    community
  • Theoretical Equipoise
  • Genuine uncertainty over whether Treatment A is
    better than Treatment B in Patient Population
  • Easily disturbed by investigator bias or hunches
  • balancing on a knifes edge
  • Unethical to continue research once disturbed

16
Clinical EquipoiseA Community Uncertainty
  • Sets out a standard of social approval of
    research by IRBs
  • Shifts moral locus from individual PI to members
    of the relevant, expert, clinical community
  • Progress relies on consensus within medical and
    research communities
  • Community of expert practitioners decide whether
    there is genuine uncertainty, expressed by
    honest, professional disagreement.

17
The work of Benjamin Freedman (1951-1997)
  • Freedman. Equipoise and The Ethics of Clinical
    Research. NEJM 1987317141-45.
  • Completely reframed clinical trials and
    investigator responsibilities
  • Landmark research ethics article, generating
    entire body of literature
  • Freedmans Legacy
  • Reframing issues related to consent valid
    versus ignorant consent
  • Reframing Ramsey/ McCormack debate regarding NT
    research in children
  • Coining clinical equipoise

18
Clinical Trials Do We Start in Equipoise?
  • An investigator has a hunch that Treatment A is
    superior to Treatment B but there is no evidence
    yet to support her hunch.
  • Do all populations respond to a treatment in the
    same way?
  • Pharmagogenetics
  • International study sites

19
International Research and Equipoise
  • Example Placebo-controlled trial of short-course
    of AZT for women in Uganda (AIDS clinical trial
    group 076 protocol)
  • Ugandan women are randomized to nothing or
    treatment we already know is effective and better
  • M. Angell (NEJM, 1997) When effective treatment
    exists, a placebo may not be used
  • Must use best KNOWN treatment for control group

20
International Research and Equipoise
  • Are treatment contexts similar?
  • Equipoise may exist when we change the treatment
    population in significant ways (London, 2001)
  • Are U.S. and Uganda the same treatment contexts?
  • Is nothing the prevailing standard of care?
  • Are there significant physiological differences
    that would change responses to AZT? (E.g. anemia)
  • Malnourished women versus well-nourished women
  • No access to healthcare at all versus wide access
    to healthcare

21
Rural Populations and Equipoise
  • Are treatment contexts similar?
  • Equipoise may exist when we change the treatment
    population in significant ways (London, 2001)
  • Is Eastern KY the same treatment context as NYC?
  • Are there significant physiological differences
    that would change responses treatments in urban
    versus rural pops?

22
Conclusions about Equipoise
  • Equipoise is the moral underpinning of enrolling
    participants in clinical trials
  • Moral locus of uncertainty should probably reside
    with relevant experts within the clinical
    community
  • Individual uncertainty (FE or Peto) cannot be
    disturbed by biases, hunches, etc.
  • Individual uncertainty must at the minimum rely
    on some evidentiary standard to be disturbed
  • Moral distress over individual uncertainty can be
    created if clinical equipoise is not the standard
  • New interpretations of FE, Peto and Freedman are
    still reframing equipoise (Weijer, London).
Write a Comment
User Comments (0)
About PowerShow.com